triiodothyronine has been researched along with Cardiomyopathy, Congestive in 16 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Low plasma triiodothyronine (T(3)) levels are considered a prognostic predictor of death in heart failure (HF) patients." | 7.77 | Low plasma triiodothyronine levels in heart failure are associated with a reduced anabolic state and membrane damage. ( Acosta, A; Anker, S; Boero, L; Brenta, G; Brites, F; Gómez Rosso, L; Sutton, M; Thierer, J; Vainstein, N, 2011) |
| "Although low levels of free triiodothyronine and high levels of brain natriuretic peptide have been shown as independent predictors of death in chronic heart failure patients, few studies have compared their prognostic values." | 7.76 | Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure. ( Acar, E; Ertas, G; Kilic, T; Kozdag, G; Sahin, T; Ural, D, 2010) |
| "Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 7.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 7.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
| "Low plasma triiodothyronine (T(3)) levels are considered a prognostic predictor of death in heart failure (HF) patients." | 3.77 | Low plasma triiodothyronine levels in heart failure are associated with a reduced anabolic state and membrane damage. ( Acosta, A; Anker, S; Boero, L; Brenta, G; Brites, F; Gómez Rosso, L; Sutton, M; Thierer, J; Vainstein, N, 2011) |
| "Although low levels of free triiodothyronine and high levels of brain natriuretic peptide have been shown as independent predictors of death in chronic heart failure patients, few studies have compared their prognostic values." | 3.76 | Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure. ( Acar, E; Ertas, G; Kilic, T; Kozdag, G; Sahin, T; Ural, D, 2010) |
| "Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 3.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 3.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
| "Whether D3 induction occurs in dilated cardiomyopathy is unknown." | 1.46 | Myocardial Induction of Type 3 Deiodinase in Dilated Cardiomyopathy. ( Dorfman, DM; Huang, SA; Jay, PY; Jugo, RH; Maynard, MA; Padera, RF; Wassner, AJ; Zavacki, AM, 2017) |
| "Resolution of dilated cardiomyopathy with normalization of systolic function was achieved in five patients, and improvement from severe to mild left ventricular dysfunction was observed in two patients." | 1.29 | Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism. ( Challapalli, S; Patterson, C; Umpierrez, GE, 1995) |
| "For both control and dilated cardiomyopathy groups, 3,5,3'-triiodo-L-thyronine caused a significant increase in myocyte contractile function." | 1.29 | The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and beta-adrenergic responsiveness in dilated cardiomyopathy. ( Crawford, FA; Kato, S; Spinale, FG; Walker, JD, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, HY | 1 |
| Sun, L | 1 |
| Zhu, YQ | 1 |
| Chen, QS | 1 |
| Zhu, WW | 1 |
| Toorabally, MB | 1 |
| Chen, XG | 1 |
| Zhang, FX | 1 |
| Wassner, AJ | 1 |
| Jugo, RH | 1 |
| Dorfman, DM | 1 |
| Padera, RF | 1 |
| Maynard, MA | 1 |
| Zavacki, AM | 1 |
| Jay, PY | 1 |
| Huang, SA | 1 |
| Zhang, K | 1 |
| Wang, W | 1 |
| Zhao, S | 1 |
| Katz, SD | 1 |
| Iervasi, G | 2 |
| Gerdes, AM | 1 |
| Tang, YD | 1 |
| Oliveros-Ruiz, L | 1 |
| Vallejo, M | 1 |
| Diez Canseco, LF | 1 |
| Cárdenas, M | 1 |
| Hermosillo, JA | 1 |
| Madan, N | 1 |
| Tiwari, N | 1 |
| Stampfer, M | 1 |
| Schubart, U | 1 |
| Wang, YY | 1 |
| Morimoto, S | 1 |
| Du, CK | 1 |
| Lu, QW | 1 |
| Zhan, DY | 1 |
| Tsutsumi, T | 1 |
| Ide, T | 1 |
| Miwa, Y | 1 |
| Takahashi-Yanaga, F | 1 |
| Sasaguri, T | 1 |
| Kozdag, G | 2 |
| Ertas, G | 1 |
| Kilic, T | 1 |
| Acar, E | 1 |
| Sahin, T | 2 |
| Ural, D | 2 |
| Brenta, G | 1 |
| Thierer, J | 1 |
| Sutton, M | 1 |
| Acosta, A | 1 |
| Vainstein, N | 1 |
| Brites, F | 1 |
| Boero, L | 1 |
| Gómez Rosso, L | 1 |
| Anker, S | 1 |
| Vural, A | 1 |
| Agacdiken, A | 1 |
| Kahraman, G | 1 |
| Ural, E | 1 |
| Komsuoglu, B | 1 |
| Berti, P | 1 |
| Materazzi, G | 1 |
| Bogazzi, F | 1 |
| Ambrosini, CE | 1 |
| Martino, E | 1 |
| Miccoli, P | 1 |
| Pingitore, A | 1 |
| Galli, E | 1 |
| Barison, A | 1 |
| Iervasi, A | 1 |
| Scarlattini, M | 1 |
| Nucci, D | 1 |
| L'abbate, A | 1 |
| Mariotti, R | 1 |
| Pimenov, LT | 1 |
| Leshchinskiĭ, LA | 1 |
| Umpierrez, GE | 1 |
| Challapalli, S | 1 |
| Patterson, C | 1 |
| Walker, JD | 1 |
| Crawford, FA | 1 |
| Kato, S | 1 |
| Spinale, FG | 1 |
| Moruzzi, P | 1 |
| Doria, E | 1 |
| Agostoni, PG | 1 |
| Capacchione, V | 1 |
| Sganzerla, P | 1 |
| Valensise, H | 1 |
| Civitella, C | 1 |
| Garzetti, GG | 1 |
| Romanini, C | 1 |
2 trials available for triiodothyronine and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study.
Topics: Aged; Cardiomyopathy, Dilated; Chronic Disease; Euthyroid Sick Syndromes; Female; Heart; Heart Failu | 2008 |
Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy.
Topics: Aged; Cardiac Output; Cardiomyopathy, Dilated; Dobutamine; Echocardiography; Exercise Test; Exercise | 1994 |
14 other studies available for triiodothyronine and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Prognostic value of free triiodothyronine in patients with dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Humans; Prognosis; Thyroid Function Tests; Thyrotropin; Thyroxine; Triiodot | 2020 |
Myocardial Induction of Type 3 Deiodinase in Dilated Cardiomyopathy.
Topics: Animals; Cardiomyopathy, Dilated; Disease Models, Animal; Disease Progression; Iodide Peroxidase; Mi | 2017 |
Long-term prognostic value of combined free triiodothyronine and late gadolinium enhancement in nonischemic dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Cause of Death; China; Contrast Media; Female; Follow-Up Studies; Gadoliniu | 2018 |
Determinants of thyrotoxic cardiomyopathy recovery.
Topics: Adrenergic beta-Antagonists; Adult; Cardiomyopathy, Dilated; Echocardiography; Female; Humans; Male; | 2013 |
Hypothyroid heart: myxoedema as a cause of reversible dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Female; Heart; Humans; Hypothyroidism; Middle Aged; Myxedema; Thyroxine; Tr | 2015 |
Up-regulation of type 2 iodothyronine deiodinase in dilated cardiomyopathy.
Topics: Animals; Antithyroid Agents; Cardiomyopathy, Dilated; Cells, Cultured; Cyclic AMP; Disease Models, A | 2010 |
Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.
Topics: Aged; Biomarkers; Cardiomyopathy, Dilated; Chi-Square Distribution; Chronic Disease; Down-Regulation | 2010 |
Low plasma triiodothyronine levels in heart failure are associated with a reduced anabolic state and membrane damage.
Topics: Aged; Biomarkers; Cardiomyopathy, Dilated; Echocardiography; Electric Impedance; Exercise Test; Fema | 2011 |
Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Case-Control Studies; Female; Follow-Up Studies; Humans; Male; | 2005 |
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study.
Topics: Aged; Amiodarone; Anesthesia, Local; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nerve B | 2007 |
[Thyroid hormone changes (iodothyroninemia) in patients with acute myocardial infarction, and their clinical significance].
Topics: Adult; Angina Pectoris; Cardiomyopathy, Dilated; Humans; Middle Aged; Myocardial Infarction; Prognos | 1984 |
Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Echocardiography; Female; Heart Failure; Hu | 1995 |
The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and beta-adrenergic responsiveness in dilated cardiomyopathy.
Topics: Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Cells, Cultured; Isoproterenol; Myocardial Con | 1994 |
Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; Echo | 1992 |